MAPT and Alzheimer disease: The ultrasensitive tau seed amplification assay detected that seeding activity of tau aggregates in AD and CTE was markedly higher than in other tauopathies, such as Pick's disease, and seed concentrations in the brains of two CTE cases were comparable to the lowest concentrations in AD brains (62).